E3 ubiquitin ligase RNF180 reduces sensitivity of triple-negative breast cancer cells to Gefitinib by downregulating RAD51

Title
E3 ubiquitin ligase RNF180 reduces sensitivity of triple-negative breast cancer cells to Gefitinib by downregulating RAD51
Authors
Keywords
Triple-negative breast cancer, Gefitinib, Drug resistance, E3 ubiquitin protein ligase, Ring finger protein 180, RAD51
Journal
CHEMICO-BIOLOGICAL INTERACTIONS
Volume 354, Issue -, Pages 109798
Publisher
Elsevier BV
Online
2022-01-06
DOI
10.1016/j.cbi.2022.109798

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now